Drug-Resistant Tuberculosis

CHA

Tag: Drug-Resistant Tuberculosis

World Tuberculosis Day: Treating the untreatable

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....

Read more

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF   For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB).  Pooja,...

Read more

Mumbai: A new life with new tuberculosis drugs

Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...

Read more

India: Renewed hope with new drugs

Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons